• Cy3 NHS ester (non-sulfonated): Technical Guide for Protein

  2026-06-02

  Cy3 NHS ester (non-sulfonated) addresses the need for precise, high-sensitivity labeling of proteins, peptides, and oligonucleotides where direct water solubility is not required. It is ideal for workflows requiring robust orange fluorescence compatible with standard TRITC filter sets. However, its requirement for organic co-solvents limits use with highly sensitive or unstable biomolecules.

• Palbociclib (PD0332991): Optimizing Cell Cycle Arrest in Tum

  2026-06-02

  Palbociclib (PD0332991) Isethionate unlocks precise cell cycle G0/G1 arrest and apoptosis induction in physiologically relevant cancer models. This article delves into advanced workflows, assembloid-based drug testing, and actionable troubleshooting—bridging bench research with robust translational insight.

• Apigenin: HDAC Inhibition and Neuroprotection in Bench Resea

  2026-06-01

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) enables researchers to model both cancer cell growth inhibition and neuroprotective pathways in vitro and in vivo. This article translates cutting-edge network medicine findings into actionable protocols, troubleshooting guidance, and comparative advantages for advanced disease modeling.

• Limb Organoid Models Reveal AER Signaling in Cell Fate and P

  2026-06-01

  This study introduces a robust, stem cell-derived limb organoid system that enables dissection of the apical-ectodermal ridge (AER) signaling center’s role in cell fate and spatial organization. The findings advance limb morphogenesis research by providing a scalable platform for investigating multi-lineage interactions and signaling gradients that shape tissue development.

• NADPH Oxidase-Derived ROS Regulate Arterial Contraction via

  2026-05-31

  This study demonstrates that NADPH oxidase-derived reactive oxygen species (ROS) promote arterial contraction in early postnatal rats by activating L-type voltage-gated Ca2+ channels (LTCC), rather than through canonical Rho-kinase, PKC, or Src-kinase pathways. The findings refine the mechanistic understanding of vascular tone regulation during early development and highlight LTCC as a key effector of ROS-mediated vasomotor responses.

• CDK7 D97N Mutation Drives Resistance to Non-Covalent Inhibit

  2026-05-30

  This study uncovers how a conserved mutation in CDK7 (D97N) in cancer cells confers resistance to non-covalent CDK7 inhibitors while leaving sensitivity to covalent inhibitors intact. The findings have immediate implications for precision cancer therapy, drug resistance monitoring, and the selection of transcription regulation inhibitors for research and clinical applications.

• Scenario-Driven Solutions with Doxorubicin (Adriamycin) HCl

  2026-05-29

  This article delivers evidence-backed, scenario-driven guidance for biomedical researchers using Doxorubicin (Adriamycin) HCl (SKU A1832) in cell viability, apoptosis, and cardiotoxicity assays. Each section addresses real laboratory challenges, providing actionable insights and protocol recommendations. By highlighting APExBIO’s Doxorubicin HCl as a reliable tool for reproducible and high-sensitivity workflows, the article empowers labs to optimize experimental outcomes.

• Apigenin (SKU N1828): Reliable Solutions for Cell Viability

  2026-05-29

  This article delivers a scenario-driven guide for leveraging Apigenin (SKU N1828) from APExBIO in cell viability, proliferation, and neuroprotection assays. Drawing on peer-reviewed data and real laboratory challenges, it highlights protocol optimization, reproducibility, and data interpretation, ensuring researchers can confidently deploy Apigenin for both oncology and neurodegeneration studies.

• NSC 87877: Illuminating Shp2 Pathways in Neuroinflammation a

  2026-05-28

  Explore how NSC 87877, a selective Shp2 inhibitor, empowers advanced research into neuroinflammation and cancer signaling. This deep dive uncovers its mechanistic impact and translational applications, revealing new insights beyond standard protocols.

• Everolimus (RAD001) in Translational Oncology: Pathway, Prec

  2026-05-28

  Explore how Everolimus (RAD001) enables advanced mTOR pathway inhibition and refined cancer research, with a unique focus on assay design and translational relevance. This article delivers scientific depth and actionable insights not found in typical workflows.

• Gramine Induces Ferroptosis via CUL3–MTDH in TNBC Models

  2026-05-27

  The reference study uncovers how Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively induces ferroptosis in triple-negative breast cancer by modulating the CUL3–MTDH ubiquitination axis. These findings establish a novel mechanistic pathway, highlighting Gramine’s translational value for cancer biology research and ferroptosis studies.

• Anlotinib Hydrochloride: Deep Mechanistic Insights for Trans

  2026-05-27

  Explore the advanced mechanisms and unique translational applications of Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in angiogenesis and cancer research. This article reveals nuanced practical guidance and protocol parameters grounded in primary literature.

• FXR-KLF11 Axis: CDCA Mitigates CI-AKI via JAK2/STAT3 Suppres

  2026-05-26

  This study uncovers a mechanistic pathway in which Chenodeoxycholic Acid (CDCA) activates FXR, leading to transcriptional upregulation of KLF11 and subsequent suppression of the JAK2/STAT3 signaling pathway in contrast-induced acute kidney injury (CI-AKI). The findings offer a foundation for targeting the FXR-KLF11 axis as a prophylactic strategy in renal injury models and inform research into nuclear receptor signaling.

• Flavopiridol (L868275): Integrating ER Stress and CDK Inhibi

  2026-05-26

  Explore how Flavopiridol (L868275) uniquely bridges cyclin-dependent kinase inhibition with endoplasmic reticulum stress pathways in cancer research. Discover advanced insights that go beyond cell cycle arrest, with practical protocols and novel mechanistic context.

• PKH26 Red Fluorescent Cell Linker Kit: Protocol & Use Guide

  2026-05-25

  The PKH26 Red Fluorescent Cell Linker Kit addresses the challenge of stable, membrane-specific fluorescent labeling for cell biology research. It is applicable for cell tracing and proliferation detection in vitro and in vivo, but should not be used for intracellular or non-membrane labeling applications.

16294 records 1/1087 page Next 12345 下5页 Last page